High Tower Advisors, LLC Gossamer Bio, Inc. Put Options Transaction History
High Tower Advisors, LLC
- $84.5 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
178Shares Held
163MCall Options Held
8.11MPut Options Held
211K-
Nea Management Company, LLC Timonium, MD18.1MShares$49 Million2.97% of portfolio
-
Octagon Capital Advisors LP New York, NY17.1MShares$46.2 Million14.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$32.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$21.8 Million9.24% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.13MShares$16.6 Million6.11% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $255M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...